Котляров А.А., Мосина Л.М., Чибисов С.М. и др. Антиаритмическая терапия пароксизмальных тахикардий и экстрасистолий у больных с дисфункцией синусового узла. Клиническая медицина. 2012; 9 (20).
Мясников А.Л. Гипертоническая болезнь и атеросклероз. 1965. 615 c.
Aaron S.D., Vandemheen K.L., Maltais F. et al. TNFa antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax. 2013; 68 (2): 142-148.
Abutaleb N. Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. Nephrol Dial Transplant. 2007; 22 (9): 2728-2729.
Adams T.D., Davidson L.E., Litwin S.E. et al. Health Benefits of Gastric Bypass Surgery After 6 Years. JAMA. 2012; 308 (11): 1122-1131.
Afkarian M., Sachs M.C., Kestenbaum B. et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013; DOI: 10.1681/ASN.2012070718.
Aguilar D., Bozkurt B., Ramasubbu K. et al. Relationship of Hemoglobin A1C and Mortality in Heart Failure Patients With Diabetes. J Am Coll Cardiol 2009; 54 (5): 422-428.
Ahimastos A.A., Walker P.J., Askew C. et al. Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication: A Randomized Controlled Trial. JAMA. 2013; 309 (5): 453-460.
Ahmad S., Xue Z., Silverman A. et al. Complexity of the Relation Between Hemoglobin A1C, Diabetes Mellitus, and Progression of Coronary Narrowing in Postmenopausal Women. The American journal of cardiology. 2013; 111 (6): 793-799.
Ahmed A., Rich M.W., Zile M. et al. Renin-Angiotensin Inhibition in Diastolic Heart Failure and Chronic Kidney Disease. The American Journal of Medicine. 2013; 126 (2): 150-161.
Ahmed I., Gertner E. Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels. Am J Med. 2012; 125 (3): 265-269.